IP Verse

Bioverativ Therapeutics Inc. opposition analysis

COMPANY ANALYSIS

Patent Number:

Title:

Sodium Chloride Solution For Drug Reconstitution Or Dilution

Applicant:

Opposition Date:

May 14, 2020

Patent Number:

Title:

Compositions And Methods For Enhancing Coagulation Factor Viii Function

Applicant:

Opposition Date:

Aug 21, 2019

Patent:

Grant Date:

Jan 24, 2024

Title:

Optimized Factor Viii Gene

Oppositions:

Patent:

Grant Date:

Jun 29, 2022

Title:

Cell Line Expressing Single Chain Factor Viii Polypeptides And Uses Thereof

Oppositions:

Patent Number	Title	Applicant	Opposition Date
EP3225233	Sodium Chloride Solution For Drug Reconstitution Or Dilution	WYETH LLC	May 14, 2020
EP2482841	Compositions And Methods For Enhancing Coagulation Factor Viii Function	THE CHILDREN'S HOSPITAL OF PHILADELPHIA	Aug 21, 2019

Patent Number	Grant Date	Title	Total Oppositions
EP2956477	Jan 24, 2024	Optimized Factor Viii Gene	1
EP2870250	Jun 29, 2022	Cell Line Expressing Single Chain Factor Viii Polypeptides And Uses Thereof	2

EUROPEAN OPPOSITIONS LIMITED

FH SERVICES LIMITED

J A KEMP LLP

Feel free to send us a message here and we will get back to you